AKT1 and cancer: Previous studies reported that Siglec-15 could affect several cancer-related pathways, including PI3K-Akt, MAPK, Hippo, and apoptosis.19,37 Whether Siglec-15 could regulate radiosensitivity and its exact mechanisms remain to be elucidated, which presents new challenges for Siglec-15 studies.